The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Why Integrating Medications and Psychosocial Interventions is Important to Successfully Address the Opioid Crisis in Canada
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Current evidence strongly supports integrated care for comorbid SUDs and psychiatric conditions.
“current evidence strongly supports an approach known as integrated care.”
From Navigating the Complex Intersection of Substance Use and Psychiatric Disorders: A Comprehensive Review (2024) · cites this paper as [14]
“Putting it All Together” advocates integrated mental health, addiction, and medical care for people with opioid use disorder (OUD). But the paper addresses OUD specifically, rather than comorbid substance use disorders and psychiatric conditions generally. “The Importance of Integrating PSIs into the Treatment of OUD” also says evidence for combining psychosocial interventions with opioid agonist treatment is mixed, so “strongly supports” overstates that evidence. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Treatment of opioid-use disorders
Schuckit, M. A. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1604339 · Cited by 540
Diacetylmorphine versus Methadone for the Treatment of Opioid Addiction
Oviedo‐Joekes, E., Brissette, S., Marsh, D. C., Lauzon, P., Guh, D. P., Anis, A. H., & Schechter, M. T. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810635 · Cited by 371
Dugosh, K., Abraham, A., Seymour, B., McLoyd, K., Chalk, M., & Festinger, D. (2016) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000193 · Cited by 333
Long-Term Course of Opioid Addiction
Hser, Y.-I., Evans, E., Grella, C., Ling, W., & Anglin, D. (2015) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000052 · Cited by 299
Hydromorphone Compared With Diacetylmorphine for Long-term Opioid Dependence
Oviedo‐Joekes, E., Guh, D. P., Brissette, S., Marchand, K., Macdonald, S., Lock, K., Harrison, S., Janmohamed, A., Anis, A. H., Krausz, M. R., et al. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.0109 · Cited by 207
Marsh, T. N., Coholic, D. A., Cote-Meek, S., & Najavits, L. M. (2015) · Harm Reduction Journal · doi:10.1186/s12954-015-0046-1 · Cited by 191
What Role Should Psychiatrists Have in Responding to the Opioid Epidemic?
Muvvala, S. B., Edens, E. L., & Petrakis, I. L. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.3123 · Cited by 19
Jayasinha, R., Nairn, S. A., & Conrod, P. (2020) · The Canadian Journal of Psychiatry · doi:10.1177/0706743720943820 · Cited by 12
Been There, Done That: Lessons from Vancouver’s Efforts to Stem the Tide of Overdose Deaths
Krausz, M. R., Wong, J. S. H., Zadeh, E. M., & Jang, K. L. (2020) · The Canadian Journal of Psychiatry · doi:10.1177/0706743720912860 · Cited by 9
Flagged first, then by citations
Cited by
Sorted by citations
Bahji, A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13040999 · Cited by 83
“Effectively addressing comorbid SUDs and psychiatric conditions demands a comprehensive treatment approach [12,14].”
BackgroundGarg, R., Kitchen, S. A., Men, S., Campbell, T. J., Bozinoff, N., Tadrous, M., Antoniou, T., Wyman, J., Werb, D., Munro, C., et al. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109459 · Cited by 15
Cannabidiol as a Harm Reduction Strategy for People Who Use Drugs: A Rapid Review
Lo, L. A., MacCallum, C. A., Nanson, K., Koehn, M., Mitchell, I., Milloy, M., Walsh, Z., & Fehr, F. C. (2023) · The Canadian Journal of Psychiatry · doi:10.1177/07067437231183525 · Cited by 13
A Call for an Evidence-Based Strategy Against the Overdose Crisis
Krausz, M. R., Westenberg, J. N., Tai, A. M. Y., Fadakar, H., Seethapathy, V., Mathew, N., Azar, P., Phillips, A. G., Schütz, C. G., Choi, F., et al. (2023) · The Canadian Journal of Psychiatry · doi:10.1177/07067437231188202 · Cited by 8
“11 When compared to Europe, treatment access and coverage in North America is signi fi cantly worse, and is far below the World Health Organization OAT coverage target of 40%.”
BackgroundHawke, L. D., Zhu, N., Relihan, J., Darnay, K., & Henderson, J. L. (2022) · The Canadian Journal of Addiction · doi:10.1097/cxa.0000000000000148 · Cited by 5
“org ing various forms of services.(37) Given the urgency of the opioid crisis, the trials must be pragmatic: they must include implementation in real-world settings and use the tools of implementation science to enable real-time intervention refinement and rapid scale-up.”
BackgroundSubstance Use and Anxiety Disorders: A Scoping Review
Goldfield, D., Zhang, M., & George, T. P. (2024) · Current Addiction Reports · doi:10.1007/s40429-024-00541-7 · Cited by 4
“This poses major obstacles to the delivery of effective treatment for those with comorbid ADs and SUDs because clinicians in either service are generally not trained to assess or treat the other condition [14 • ].”
InfluentialSelf-citationUnderstanding and Treating Dual Diagnosis: Double the Trouble
Tang, V. M., & George, T. P. (2024) · Current Addiction Reports · doi:10.1007/s40429-024-00564-0 · Cited by 4
“Nonetheless, practical recommendations can be made on the need to increase monitoring of dual diagnoses in our patients and to push for models of care in which treatment for both psychiatric and substance use disorders is integrated and collaborative [14].”
Self-citationExtended-release monthly buprenorphine injection
Cuperfain, A. B., Costa, T., & Chopra, N. (2023) · Canadian Medical Association Journal · doi:10.1503/cmaj.220730 · Cited by 3
Fehr, F. C., Lo, L. A., Nelson, C. C., Diehl, L., & Walsh, Z. (2025) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.24-00224 · Cited by 1
How Addiction Psychiatrists Add Value to (Mental) Health Care in Canada
George, T. P., Chopra, N., Franchuk, S. L., Buckley, L., & Jutras‐Aswad, D. (2025) · The Canadian Journal of Addiction · doi:10.1097/cxa.0000000000000256 · Cited by 1
Self-citationWhat Psychiatrists Should Know About Prescribed Safer Opioid Supply
Bahji, A., Danilewitz, M., Sachdev, A., Mathew, N., Lamba, W., Rafizadeh, R., Chopra, N., Dhaliwal, A., George, T. P., Crockford, D. N., et al. (2024) · The Canadian Journal of Psychiatry · doi:10.1177/07067437241289964 · Cited by 1
“6 While data are lacking speci fi cally among PWUD who engage with SOS, individuals with OUD often have comorbid trauma, mood, or anxiety disorders, and the bene fi t of concurrent psychiatric care with OAT has been established, leading to decreased hospitalizations, ER visits, and, all-cause…”
Self-citationInjection mensuelle de buprénorphine à libération prolongée
Cuperfain, A. B., Costa, T., & Chopra, N. (2023) · Canadian Medical Association Journal · doi:10.1503/cmaj.220730-f
Peer-administered Naloxone for Preventing Opioid Overdose: A Scoping Review
Dlugos, K. V., Maksyutynska, K., Kyne, L. T., Costa, T., & George, T. P. (2024) · The Canadian Journal of Addiction · doi:10.1097/cxa.0000000000000202
“9,10 Addressing the lack of accessibility to OAT, naloxone is a short-acting, high-affinity mu-opioid receptor antagonist that can be injected or administered intranasally to reverse the effects of opioids.”
BackgroundSelf-citationD’Arcey, J., Zedan, S. A., Tackaberry-Giddens, L., McIntyre, C. M., Junaid, S., Asuncion, T.-R., & Kidd, S. A. (2026) · PLOS Digital Health · doi:10.1371/journal.pdig.0001544
“Additionally, there are growing calls for the integration of evidence-based psychotherapy interventions alongside MOUD to improve retention and treatment of comorbid mental health conditions [18].”
Metadata
- Authors
- George, T. P., Welsh, L., Franchuk, S. L., & Vaccarino, F. J.
- Affiliations
- Centre for Addiction and Mental Health (CA)
- University of Guelph (CA)
- Corresponding author
- George, Tony P.
- ORCID
- George, Tony P.
- Venue
- The Canadian Journal of Psychiatry
- Publisher
- SAGE Publications
- Published
- 2021-08-23
- Volume
- 67
- Issue
- 3
- Pages
- 176-178
- ISSN
- 0706-7437 (ISSN-L)
- 1497-0015
- PMC
- PMC8935597
- OpenAlex
- W3194679402
- Cited by
- 14
- References
- 9
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 5 · 2023: 4 · 2022: 2
- FWCI
- 2.38
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Canadian Journal of Psychiatry (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (R21-DA-043949)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Keywords
- opioid epidemic, medication-assisted treatment, psychosocial interventions, integrated treatment, opioid use disorder, harm reduction, Canada
- MeSH terms
- Opioid Epidemic, Psychosocial Intervention, Analgesics, Opioid, Canada, Humans, Opioid-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
